ArticleMiddle East journal of digestive diseases2025
The Endoscopic Ultrasonography and Fine Needle Aspiration Agreement in Patients with Pancreatic Cystic Lesions, in Tehran, Iran.
Article in Middle East journal of digestive diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: IThis study aimed to investigate the concordance of endoscopic ultrasonography (EUS) results and biochemical analysis of cyst fluid obtained through fine needle aspiration (FNA) in diagnosing mucinous pancreatic cysts. Methods: In this retrospective study, the medical records of 81 patients with pancreatic cystic lesions were examined. EUS results and cyst fluid analysis (carcinoembryonic antigen [CEA] and amylase) concordance rate was evaluated, and the agreement between the two methods was assessed through Cohen's kappa coefficient. Results: The concordance rate of EUS and cyst fluid analysis with CEA cutoff point>192 ng/mL was 52.5% and 69.2%, respectively, for mucinous cystic neoplasm (MCN) and Intraductal papillary mucinous neoplasm (IPMN) diagnosis. The sensitivity and specificity of cyst fluid analysis for MCN and IPMN (taking EUS as the reference) were 59.1% and 93.33%, respectively. The positive predictive value was equal to 97.5%, and its negative predictive value was 34.14. Using the CEA<5 ng/mL cutoff point for detecting serous cystic neoplasm (SCN) cysts was associated with the sensitivity, specificity, and positive and negative predictive values of 73.3%, 78.8%, 44%, and 92.8%, respectively. The concordance rate of EUS and pancreatic cyst fluid analysis was 65.43%, with a kappa correlation coefficient of 0.326. Conclusion: The specificity and positive predictive value of CEA>192 for the diagnosis of mucinous pancreatic cysts is high, but it is associated with moderate sensitivity and a low negative predictive value. Altogether, there is a moderate agreement between the results of EUS and biochemical analysis of FNA cyst fluid in diagnosing mucinous pancreatic cysts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.